Cytek and Sysmex Europe team up to expand access to advanced clinical flow cytometry
Complementary technologies deliver an integrated, end-to-end clinical flow cytometry workflow for laboratories across Europe
18 Sept 2026
Sysmex Europe SE and Cytek Biosciences, Inc. have announced a strategic collaboration across over a dozen European countries to enhance clinical flow cytometry workflows and expand access to innovative diagnostic solutions. Together, Sysmex and Cytek will offer integrated, end-to-end solutions that support laboratories from sample preparation through advanced multi-color analysis.
The collaboration brings together the expertise and technologies of both companies to provide clinical laboratories with a broader portfolio of flow cytometry technologies that improve workflow efficiency, standardization and advanced clinical capabilities.
Clinical flow laboratories face growing demand for faster, more standardized testing while managing increasingly complex diagnostic requirements. Through this collaboration, Sysmex's established clinical flow cytometry portfolio – including the XF-1600 flow cytometer for routine testing and the PS-10 automated sample preparation system – will be complemented by Cytek's Northern Lights™-CLC spectral flow cytometer.
The complementary offering enables laboratories to perform advanced multi-color applications required for leukemia and lymphoma as well as measurable residual disease assessment, creating a comprehensive solution for specialized clinical flow cytometry laboratories.
“By combining our expertise in laboratory automation and routine flow cytometry with Cytek's leadership in spectral flow cytometry, we can now offer a unique end-to-end solution for clinical flow laboratories," said Alain Baverel, CEO of Sysmex Europe SE.
"This gives laboratories the advantage of a streamlined workflow, from automated sample preparation and routine testing to advanced spectral analysis, helping them meet growing diagnostic demands with greater efficiency and consistency."
Wenbin Jiang, Ph.D., CEO of Cytek Biosciences, added, "This collaboration brings together two leaders with a shared commitment to advancing clinical diagnostics. Cytek has transformed flow cytometry through spectral technology, and by working with Sysmex, we can extend the reach of these capabilities within clinical laboratories. Together, we're providing a comprehensive solution that helps laboratories streamline workflows while supporting increasingly complex clinical applications."
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Tags
Frequently asked questions
Show frequently asked questions
What does the Sysmex Europe and Cytek Biosciences collaboration offer clinical flow cytometry laboratories?
The collaboration provides laboratories across more than a dozen European countries with integrated, end-to-end clinical flow cytometry solutions, covering automated sample preparation, routine testing and advanced multi-color spectral analysis. It aims to improve workflow efficiency, standardization and clinical capabilities.
Which flow cytometry technologies are included in the Sysmex and Cytek portfolio?
The portfolio combines Sysmex’s XF-1600 flow cytometer for routine testing and PS-10 automated sample preparation system with Cytek’s Northern Lights™-CLC spectral flow cytometer. These complementary technologies support workflows from sample preparation through advanced analysis.
How will the collaboration support leukemia, lymphoma and measurable residual disease testing?
Cytek’s Northern Lights™-CLC spectral flow cytometer enables advanced multi-color applications required for leukemia and lymphoma testing and measurable residual disease assessment. Combined with Sysmex’s automation and routine flow cytometry technologies, it gives specialized clinical laboratories a streamlined, comprehensive workflow.